Associate Professor of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai
Psychiatry
Dr. Dan V. Iosifescu, MD
|
|
Give Review
Iosifescu practices Psychiatry. Dr. Dan V. Iosifescu is a published MD as well. He has 102 publications published. The latest was: Parcellation of the human prefrontal cortex using MRI.
Publications
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
- Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression.
- The promise of ketamine for treatment-resistant depression: current evidence and future directions.
- The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.
- Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial.
- Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: Examining the convergence of performance-based measures and s...
- A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial.
- Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
- COGNITIVE-EMOTIONAL TRAINING AS AN INTERVENTION FOR MAJOR DEPRESSIVE DISORDER.
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder.
- Rare Copy Number Variation in Treatment-Resistant Major Depressive Disorder.
- Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.
- Medication adherence in a comparative effectiveness trial for bipolar disorder.
- Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.
- Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.
- Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
- Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo con...
- The Medication Recommendation Tracking Form: A novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness...
- A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
- Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS).
- General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.
- QT interval and antidepressant use: a cross sectional study of electronic health records.
- Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for...
- Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and with...
- Feasibility of studying brain morphology in major depressive disorder with structural magnetic resonance imaging and clinical data from the electronic medical record: ...
- Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development.
- Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.
- Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: A diffusion tensor imaging study using legacy data.
- Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.
- Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies.
- Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: A 4-month prospective study.
- A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
- Diagnosis and treatment of major depressive disorder.
- Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.
- Clinical applications of neuroimaging for treating depressive disorders.
- Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.
- A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effec...
- Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
- Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task.
- Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
- Prediction of response to antidepressants: is quantitative EEG (QEEG) an alternative?
- Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study.
- Major depressive disorder and inflammatory markers in elderly patients with heart failure.
- Treating depression in the medically ill.
- Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities.
- Major depressive disorder with anger attacks and cardiovascular risk factors.
- A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.
- The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry.
- The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
- Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder.
- Empirical testing of two models for staging antidepressant treatment resistance.
- An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
- A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty...
- Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
- Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder.
- Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.
- Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.
- Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.
- The impact of medical comorbidity on acute treatment in major depressive disorder.
- Biological predictors of treatment response in affective illness.
- 31P-magnetic resonance spectroscopy and thyroid hormones in major depressive disorder: toward a bioenergetic mechanism in depression?
- Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders.
- Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire.
- Polypharmacy or medication washout: an old tool revisited.
- A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepress...
- GABA-A receptor modulators: can they offer any improvement over benzodiazepines in the treatment of anxiety disorders?
- The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression.
- Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorder.
- RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).
- Importance of retardation and fatigue/interest domains for the diagnosis of major depressive episode after stroke: a four months prospective study.
- Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study.
- Age-related changes in brain energetics and phospholipid metabolism.
- Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
- Frontal EEG predictors of treatment outcome in major depressive disorder.
- Recognition of depressive symptoms by physicians.
- Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive...
- Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.
- The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.
- Brain white-matter hyperintensities and treatment outcome in major depressive disorder.
- Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder.
- Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task.
- Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
- Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment.
- Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).
- Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I).
- Clinical characteristics of depressed patients with comorbid diabetes mellitus.
- The detection of depression in medical setting: a study with PRIME-MD.
- Obesity among outpatients with major depressive disorder.
- Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
- Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.
- Axis III disorders in treatment-resistant major depressive disorder.
- [Sudden death in acute myocardial infarct in hospitalized patients: a clinical and anatomicopathological study over a 10.5-year period].
- [The etiological spectrum of mitral insufficiency: a 10-year retrospective study].
- [The experience of paramedical personnel in the cardiopulmonary resuscitation of acute cardiac patients].
- An automated registration algorithm for measuring MRI subcortical brain structures.
- Parcellation of the human prefrontal cortex using MRI.
- Abnormal angular gyrus asymmetry in schizophrenia.
- T3 blood levels and treatment outcome in depression.
- Serum cholesterol in treatment-resistant depression.
- Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.
Schools
Carol Davila University Med and Pharm
Massachusetts General Hospital
Harvard Med School
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Massachusetts General Hospital -
Carol Davila University of Medicine and Pharmacy
Hospital
-
Mount Sinai Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Mili Priyanka, MD |
|
|
Dr. Alexandra A. Sibley, MD |
|
|
Dr. Gaston C. Baslet, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle C. Walker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura R. Fagioli Petrillo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria L. Buttolph, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eda J. Angelo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian P. Kurtz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana S. Rubin, MD
This Doctor is OpenDoctor Recommended.
|